Albumin levels associated with poor prognosis in men coinfected with HIV and HCV

This article is more than 22 years old. Click here for more recent articles on this topic

Low serum concentrations of the protein albumin at the time of HIV seroconversion are associated with poor prognosis in men coinfected with HIV and hepatitis C, according to a study published in the 15 November edition of The Lancet.

What’s more, low albumin levels are also associated with an increased risk of dying in the long-term even when traditional prognostic markers such as CD4 and CD8 counts were taken into account.

Investigators at the Royal Free Haemophilia Centre in London examined the medical records of 111 male patients coinfected with HIV and hepatitis C. The men had been infected with HIV by infected blood products between 1979 and 1985, with most men infected with hepatitis C on average five and a half years earlier. Stored serum samples allowed investigators to estimate the date of HIV seroconversion for every man. All patients were seen every three months for check-ups when blood tests were performed. These included various liver function tests, including analysis of albumin levels as well as CD4 and other immune measurements.

Glossary

seroconversion

The transition period from infection with HIV to the detectable presence of HIV antibodies in the blood. When seroconversion occurs (usually within a few weeks of infection), the result of an HIV antibody test changes from HIV negative to HIV positive. Seroconversion may be accompanied with flu-like symptoms.

 

prognosis

The prospect of survival and/or recovery from a disease as anticipated from the usual course of that disease or indicated by the characteristics of the patient.

CD8

A molecule on the surface of some white blood cells. Some of these cells can kill other cells that are infected with foreign organisms.

serum

Clear, non-cellular portion of the blood, containing antibodies and other proteins and chemicals.

 

protein

A substance which forms the structure of most cells and enzymes.

To see which test results were predictive of disease progression to an AIDS defining illness and/or death, the records of each person were reviewed from the time of HIV seroconversion to 31st August 2000. Investigators were keen to see which test results were indicative of both long-term prognosis and the likelihood of developing AIDS or dying within three months.

On average people were followed-up for an average of 13.5 years. During follow-up, 58 men (52%) developed AIDS and 68 (61%) died, 18 from liver related causes. When test results from the study population were controlled for age at HIV seroconversion and HIV treatment history, analysis showed that low baseline concentration of albumin was strongly associated with an increased risk of progressing to AIDS and dying in the longer-term, independent of other possible risk factors including CD4 and CD8 counts. However, as regards the short-term risk of dying within three months of seroconversion only CD4 and CD8 counts were significant.

Furthermore, coinfection with hepatitis C was not found to be associated with an increased risk of low baseline albumin levels and of quicker progression to AIDS and death. Nor were albumin levels found to be related to the liver-related deaths that occurred in the cohort. Indeed the investigators stress that low albumin levels were associated with poor prognosis “at a very early stage of HIV-1 infection, at a time when patients had only been infected with hepatitis C for an average of 5.7 years and most had not had significant damage to the liver.”

The investigators conclude that “the most likely explanation for our findings is that lowered concentrations of albumin are the result of a normal systemic response to a chronic inflammatory disorder.”

References

Sabin CA et al. Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study. The Lancet, 360: 1546-51, 2002.